Ahmet Tezel
Vermögen: 465 885 $ am 30.09.2026
Vermögen: 465 885 $ am 30.09.2026
Ahmet Tezel is currently Chief Innovation Officer at LivaNova Plc since 2024.
Formerly, worked as Research & Development Scientist at Inamed Corp.
from 2004 to 2006 and held the position of Global Head-Research & Development at Johnson & Johnson.
Education includes a doctorate from the University of California, Santa Barbara, and undergraduate and graduate degrees from Bogazici University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
LIVANOVA PLC 0,01 % | 11.08.2026 | 6.090 ( 0,01 % ) | 465 885 $ | 30.09.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| LIVANOVA PLC | Corporate Officer/Principal | 13.05.2024 |
| Unternehmen | Position | Ende |
|---|---|---|
Inamed Corp.
Inamed Corp. Medical SpecialtiesHealth Technology Develops and manufactures breast implants, wrinkle prevention & obesity solutions | Corporate Officer/Principal | 01.06.2006 |
| JOHNSON & JOHNSON | Technik-/Wissenschafts-/F&E-Leiter | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Inamed Corp.
Inamed Corp. Medical SpecialtiesHealth Technology Develops and manufactures breast implants, wrinkle prevention & obesity solutions | Health Technology |
Johnson & Johnson
Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
University of California, Santa Barbara
University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bogazici University
Bogazici University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LivaNova Plc
LivaNova Plc Medical SpecialtiesHealth Technology Develops electrotherapeutic devices | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen